Yahoo
BSE - Delayed Quote INR

Blue Jet Healthcare Limited (BLUEJET.BO)

504.40 +0.55 (+0.11%)
At close: October 30 at 3:27:46 PM GMT+5:30
Chart Range Bar
Loading chart for BLUEJET.BO
  • Previous Close 503.85
  • Open 500.15
  • Bid 502.90 x --
  • Ask 504.65 x --
  • Day's Range 496.65 - 510.10
  • 52 Week Range 325.20 - 688.00
  • Volume 20,195
  • Avg. Volume 32,985
  • Market Cap (intraday) 87.496B
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) 37.23
  • EPS (TTM) 13.55
  • Earnings Date (est.) --
  • Forward Dividend & Yield 1.20 (0.24%)
  • Ex-Dividend Date Sep 11, 2026
  • 1y Target Est 568.00

Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media intermediates, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related supplies to healthcare, pharma, animal feed, and food and beverages industries. It has operations in India, Norway, France, the United States, Denmark, Thailand, Spain, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

www.bluejethealthcare.com

581

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BLUEJET.BO
4.62%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

BLUEJET.BO
21.96%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

BLUEJET.BO
35.54%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

BLUEJET.BO
35.54%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 2.93B
Earnings 782.64M
Profit Margin 26.70%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
1B
2B
22.0%
24.0%
26.0%
28.0%
30.0%

Analyst Insights

View More

Analyst Price Targets

370.00 Low
568.00 Average
504.40 Current
720.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.52%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.86B

  • Net Income Avi to Common (ttm)

    2.35B

  • Diluted EPS (ttm)

    13.55

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.23B

  • Total Debt/Equity (mrq)

    3.10%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: